Evidence map›Paper›PMID 30240784›Full record

ArticleNeuropharmacology2018

Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression.

Clarissa D Staton, Jazmine D W Yaeger, Delan Khalid, Fadi Haroun, Belissa S Fernandez, Jessica S Fernandez, Bali K Summers, Tangi R Summers, Monica Sathyanesan, Samuel S Newton and 1 more

Abstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Selective orexin receptor cross-over treatment increases resilience and expression of neuroplastic signaling genes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Hypocretin in the nucleus accumbens shell modulates social approach in female but not male California mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Resilience and its correlates in patients with narcolepsy type 1.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Clarissa D StatonDepartment of Biology, University of South Dakota, Vermillion, SD 57069, USA; Neuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA; Veterans Affairs Research Service, Sioux Falls VA Health Care System, Sioux Falls, SD 57105, USA.
Jazmine D W YaegerDepartment of Biology, University of South Dakota, Vermillion, SD 57069, USA; Neuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA; Veterans Affairs Research Service, Sioux Falls VA Health Care System, Sioux Falls, SD 57105, USA.
Delan KhalidDepartment of Biology, University of South Dakota, Vermillion, SD 57069, USA; Department of Biology, University of Massachusetts, Boston, 100William T. Morrissey Blvd, Boston, MA 02125, USA.
Fadi HarounDepartment of Biology, University of South Dakota, Vermillion, SD 57069, USA; Department of Biology, University of Utah, 257 South 1400 East, Rm. 201 Salt Lake City, UT 84112-0840, USA.
Belissa S FernandezDepartment of Biology, University of South Dakota, Vermillion, SD 57069, USA.
Jessica S FernandezDepartment of Biology, University of South Dakota, Vermillion, SD 57069, USA.
Bali K SummersVermillion High School, 1001 E Main Street, Vermillion, SD 57069, USA; Department of Chemistry, Colorado State University, 1301 Center Ave Campus Delivery 1872, Ft. Collins, CO 80523-1872, USA.
Tangi R SummersDepartment of Biology, University of South Dakota, Vermillion, SD 57069, USA; Neuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA; Veterans Affairs Research Service, Sioux Falls VA Health Care System, Sioux Falls, SD 57105, USA.
Monica SathyanesanNeuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA.
Samuel S NewtonNeuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA.
Cliff H SummersDepartment of Biology, University of South Dakota, Vermillion, SD 57069, USA; Neuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA; Veterans Affairs Research Service, Sioux Falls VA Health Care System, Sioux Falls, SD 57105, USA. Electronic address: cliff@usd.edu.

Funding

Trophic Factors in CognitionR01MH106640 · NIMH · UNIVERSITY OF SOUTH DAKOTA · PI SATHYANESAN, SAMUEL NEWTON · 2016 to 2025
$3.7M
Amygdalar Orexin Modulation of Affective DisordersR15MH104485 · NIMH · UNIVERSITY OF SOUTH DAKOTA · PI SUMMERS, CLIFF H · 2015 to 2015
$426k
NIMH NIH HHS R01 MH106640NIMH NIH HHS R15 MH104485
6 · The paper itself

Abstract

Knockdown of orexin/hypocretin 2 receptor (Orx

Indexed as

AmygdalaAnimalsAnxietyConditioning, PsychologicalDepressionFearFreezing Reaction, CatalepticMaleMice, Inbred C57BLNeuronsOrexin Receptor AntagonistsOrexin ReceptorsOrexinsPsychotropic DrugsReflex, StartleResilience, PsychologicalOrexin Receptor AntagonistsOrexin ReceptorsOrexinsPsychotropic Drugs[Ala11, d-Leu15]–Orx(B), a modified Orx(B) peptide used as an Orx(2) receptor agonistAnxietyDefeatDepressionFear conditioningFreezingHypocretinMK-1064, 5″-chloro-N-[(5,6-dimethoxy-2-pyridinyl)methyl]-[2,2':5′,3″-terpyridine]-3′-carboxamide - an Orx(2) antagonistResilienceStartleStress Alternatives ModelSusceptibility

Identifiers

PMID30240784
PMCPMC6275094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.